Xultophy 100/3.6 recalls
Xultophy 100/3.6 products have been recalled 1 time, most recently on 21 Apr 2021. The recalling company is usually Novo Nordisk. The most common reason is temperature abuse.
Total recalls1since 2021
Last 12 months0reported
Class I1100% of total
Ongoing0latest 21 Apr 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 100%Class II 0 0%Class III 0 0%
Why xultophy 100/3.6 is recalled
Companies
Product types
By year
All xultophy 100/3.6 recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Xultophy 100/3.6 (insulin degludec recalled by Novo NordiskXultophy 100/3.6 | Novo Nordisk | Temperature Abuse | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.